71 related articles for article (PubMed ID: 6676668)
21. Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype.
Ghosh SK; White LM; Ghosh R; Bankert RB
J Immunol; 1990 Jul; 145(1):365-70. PubMed ID: 1972719
[TBL] [Abstract][Full Text] [Related]
22. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells.
Hamaoka T; Shimizu J; Suda T; Fujiwara H
Princess Takamatsu Symp; 1988; 19():265-75. PubMed ID: 3269360
[TBL] [Abstract][Full Text] [Related]
23. Effects of experimental hyper- and hypothyroidism on natural defense activities against Lewis lung carcinoma and its spontaneous pulmonary metastases in C57BL/6 mice.
Kinoshita S; Sone S; Yamashita T; Tsubura E; Ogura T
Tokushima J Exp Med; 1991 Jun; 38(1-2):25-35. PubMed ID: 1948998
[TBL] [Abstract][Full Text] [Related]
24. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
25. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
Olsson L; Kiger N; Kronstrom H
Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
[TBL] [Abstract][Full Text] [Related]
27. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.
Zou JP; Shimizu J; Ikegame K; Yamamoto N; Ono S; Fujiwara H; Hamaoka T
J Immunol; 1992 Jan; 148(2):648-55. PubMed ID: 1345922
[TBL] [Abstract][Full Text] [Related]
28. Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy.
Ophir R; Pecht M; Keisari Y; Rashid G; Lourie S; Meshorer A; Ben-Efraim S; Trainin N; Burstein Y
Immunopharmacol Immunotoxicol; 1996 May; 18(2):209-36. PubMed ID: 8771368
[TBL] [Abstract][Full Text] [Related]
29. Analysis of immunosuppressor cells induced by immunization of solubilized tumor-associated antigens prepared from a rat fibrosarcoma.
Minami A
Nihon Seikeigeka Gakkai Zasshi; 1981 Aug; 55(8):779-92. PubMed ID: 6171602
[TBL] [Abstract][Full Text] [Related]
30. Intrasplenic administration of interleukin-2 to potentiate specific chemoimmunotherapy in tumor-bearing mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Nov; 46(11):5606-10. PubMed ID: 2875791
[TBL] [Abstract][Full Text] [Related]
31. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
32. Plasma membrane microviscosity of Lewis lung carcinoma cells derived from local growth and pulmonary metastases.
Rivnay B; Gorelik E; Segal S; Shinitzky M
Invasion Metastasis; 1981; 1(2):99-110. PubMed ID: 7188384
[TBL] [Abstract][Full Text] [Related]
33. Xenogeneic DNA immunization in melanoma models for minimal residual disease.
Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN
J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.
Porgador A; Tzehoval E; Katz A; Vadai E; Revel M; Feldman M; Eisenbach L
Cancer Res; 1992 Jul; 52(13):3679-86. PubMed ID: 1617640
[TBL] [Abstract][Full Text] [Related]
35. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
Eur J Immunol; 1988 Nov; 18(11):1773-8. PubMed ID: 2974424
[TBL] [Abstract][Full Text] [Related]
36. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of growth and metastases in mice by immunization with cholesterol hemisuccinate-enriched tumor cells.
Skornick Y; Gorelik E; Klausner J; Shinitzky M; Sindelar WF
Cancer Lett; 1984 Dec; 25(2):153-61. PubMed ID: 6509434
[TBL] [Abstract][Full Text] [Related]
38. Differences in cell surface antigens of tumor metastases and those of the local tumor.
Fogel M; Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1979 Mar; 62(3):585-8. PubMed ID: 84091
[TBL] [Abstract][Full Text] [Related]
39. Blastogenic response of spleen cells from C1300 neuroblastoma-bearing mice to tumor cells or soluble and insoluble tumor antigens.
Sugimoto T; Sawada T; Tozawa M; Kusunoki T; Kishida T
Gan; 1979 Jun; 70(3):327-36. PubMed ID: 157310
[TBL] [Abstract][Full Text] [Related]
40. Effect of splenectomy on the progression of postoperative pulmonary metastases of the 3LL tumor.
Ron Y; Gorelik E; Feldman M; Segal S
Eur J Cancer Clin Oncol; 1982 Apr; 18(4):391-7. PubMed ID: 6889517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]